课题基金 / 基金详情

Intestinal Barrier Function: Protective Effects of Curcumin

Intestinal Barrier Function: Protective Effects of Curcumin
肠道屏障功能:姜黄素的保护作用
批准号:
8015093
负责人:
Fayez Khalaf Ghishan
金额:
$37.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-15 至 2014-04-30

项目摘要

项目成果

Fayez Khalaf Ghishan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肠上皮单分子层不仅在调节跨细胞和细胞旁营养吸收方面起着至关重要的作用,而且还提供了一种天然屏障,可以抵御致病菌和共生细菌以及微生物和膳食抗原。这种保护屏障的破坏与急性疾病的发病机制有关,如细菌易位导致败血症和多器官系统衰竭。它还与几种慢性疾病有关,这些疾病起源于婴儿期,并在以后的生活中表现出来。这些包括特应性疾病,如湿疹、食物过敏、乳糜泻肠病、1型糖尿病、哮喘和炎症性肠病。肠屏障功能障碍的重要诱导剂包括促炎细胞因子(与IFN-?作为一个典型的屏障破坏细胞因子),浸润和转运中性粒细胞及其酶产物。慢性和严重的中性粒细胞浸润、经上皮迁移以及上皮和细胞外基质的酶和氧化损伤,显著地促进了上皮屏障的损伤。在许多人类炎症性疾病中,包括缺血性肠损伤、坏死性小肠结肠炎和特发性炎症性肠病,强烈的中性粒细胞经上皮迁移是一个普遍的特征,并与疾病病理生理相关。在本研究中,我们假设姜黄素通过抑制IFN-?CEC中的信号传导,抑制中性粒细胞募集和根尖保留,以及彻底抑制中性粒细胞在转运过程中对屏障功能的有害影响。正如结肠炎动物模型和溃疡性结肠炎患者临床试验所证明的那样,这些作用可能是姜黄素对肠道炎症的保护作用的基础。我们建议在以下三个特定目标中解决姜黄素的这些新功能:(1)确定姜黄素对IFN-?结肠细胞中的信号传导;(2)明确姜黄素抑制中性粒细胞趋化和趋化作用的分子机制;(3)探讨姜黄素对中性粒细胞诱导的上皮功能障碍保护作用的分子机制。综上所述,该项目将为姜黄素改善肠道屏障功能的机制和分子靶点提供新的信息。
英文摘要
DESCRIPTION (provided by applicant): The intestinal epithelial monolayer pays a crucial role not only in regulating transcellular and paracellular nutrient absorption, but also by providing an innate barrier against pathogenic and commensal bacteria and microbial and dietary antigens. Breakdown of this protective barrier has been implicated in the pathogenesis of acute illnesses such as bacterial translocation leading to sepsis and multiple organ system failure. It also has been implicated in several chronic diseases having their origins during infancy that manifest in later life. These include atopic disease such eczema, food allergies, celiac enteropathy, type 1 diabetes, asthma, and inflammatory bowel disease. Important inducers of intestinal barrier dysfunctions include proinflammatory cytokines (with IFN-? as a prototypical barrier-damaging cytokine) and infiltrating and translocating neutrophils and their enzymatic products. Chronic and severe neutrophil infiltration, transepithelial migration and enzymatic and oxidative damages of the epithelium and the extracellular matrix, significantly contribute to the impairment of the epithelial barrier. In a number of inflammatory human diseases, including ischemic bowel injury, necrotizing enterocolitis, and idiopathic inflammatory bowel disease, intense neutrophil transepithelial migration is a prevalent feature and correlates with disease pathophysiology. In this proposal, we hypothesize that curcumin improves intestinal barrier through inhibition of IFN-? signaling in the CEC, inhibition of neutrophil recruitment and apical retention, and thorough inhibition of the detrimental effects of neutrophils on the barrier function during transmigration. These effects likely underlie the demonstrated protective effects of curcumin in intestinal inflammation, as demonstrated in animal models of colitis and in the clinical trial with ulcerative colitis patients. We propose to address these newly attributed functions of curcumin in three specific aims tailored to (1) identify the molecular mechanism of the inhibitory effects of curcumin on IFN-? signaling in the colonocytes; (2) identify the molecular mechanisms of inhibitory effects of curcumin on neutrophil chemokinesis and chemotaxis; and (3) to characterize the molecular mechanisms of the protective effects of curcumin on neutrophil-induced epithelial dysfunction. In summary, the proposed project will provide novel information about the mechanisms and molecular targets of curcumin in improving the intestinal barrier function. PUBLIC HEALTH RELEVANCE: This proposal is focused on a clinically relevant aspect of numerous intestinal and extraintestinal disorders initiated or exacerbated by a dysfunction or failure of the intestinal epithelial barrier. Nutritional interventions, such as with the described natural compound, curcumin, hold promise as effective supplemental therapy which may lead to improvement of symptoms, decreased relapse rate in chronic inflammatory conditions, and overall provide easily tolerated and inexpensive means of improving life quality in patients with recurring inflammatory conditions of the bowel.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARP1 and PARylation as novel effectors of gut inflammation
  • 批准号:
    10679646
  • 项目类别:
  • 资助金额:
    $61.55万
  • 财政年份:
    2023
  • 负责人:
    Fayez Khalaf Ghishan
  • 依托单位:
Novel Roles of Sodium Hydrogen Exchanger 8 (NHE8) in Mucosal Homeostasis
  • 批准号:
    9402244
  • 项目类别:
  • 资助金额:
    $34.54万
  • 财政年份:
    2017
  • 负责人:
    Fayez Khalaf Ghishan
  • 依托单位:
Novel Roles of Sodium Hydrogen Exchanger 8 (NHE8) in Mucosal Homeostasis
  • 批准号:
    9980395
  • 项目类别:
  • 资助金额:
    $34.54万
  • 财政年份:
    2017
  • 负责人:
    Fayez Khalaf Ghishan
  • 依托单位:
Modulation of dendritic cell function in the pathogenesis of Inflammatory Bowel Diseases
  • 批准号:
    9349503
  • 项目类别:
  • 资助金额:
    $34.54万
  • 财政年份:
    2016
  • 负责人:
    Fayez Khalaf Ghishan
  • 依托单位:
海外基金